Pattern-recognition receptor and inflammasome component (PRRs/Inflammasomes)

Pattern-recognition receptors (PRRs) and inflammasome components are fundamental sensors of the innate immune system that identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Janeway et al., 2001). PRRs, such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), initiate signaling cascades that lead to the production of pro-inflammatory cytokines and interferons (NIH, 2023). Inflammasomes are cytosolic multiprotein complexes, such as the NLRP3 inflammasome, that activate caspase-1, leading to the maturation of interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) (Nature Reviews Immunology, 2020). This process also triggers pyroptosis, a form of programmed inflammatory cell death that helps eliminate infected cells (PubMed, 2021). Dysregulation of these pathways is a hallmark of various inflammatory, autoimmune, and metabolic diseases, including gout, atherosclerosis, and neurodegeneration (PubMed, 2021). Consequently, these components are high-priority therapeutic targets in modern drug discovery (StatPearls, 2023). Therapeutic strategies include the use of TLR agonists as vaccine adjuvants and cancer immunotherapies (PubChem, 2023). Conversely, small-molecule inhibitors of NLRP3 or caspase-1 are being developed to treat chronic inflammatory conditions (Nature Reviews Drug Discovery, 2022). Monoclonal antibodies targeting downstream products like IL-1β are already in clinical use for autoinflammatory syndromes (NIH, 2023). Overall, modulating these sensors provides a powerful means to regulate the body's primary immune response (Janeway et al., 2001).

Other names

Pattern recognition receptorsInnate immune sensorsInflammasome machineryPRR signaling components

Inhibition of NLRP3 ATPase activity, agonism of Toll-like receptors (TLRs), and blockade of inflammasome assembly or caspase-1 activation.